CDKN2B-AS1 and melanoma: Inhibition of the JNK and p38 pathways in MTAP-ANRIL melanoma cells increased the expression level of E-cadherin but decreased the expression levels of SNAIL1, N-cadherin, cyclin B1 and cyclin D1 that were increased by MTAP-ANRIL (Fig. 4B).